Section 251: Advanced Vision and Eye Movement Therapy in CBS/PSP

Section 251: Advanced Vision and Eye Movement Therapy in CBS/PSP

Overview

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Section 251: Advanced Vision and Eye Movement Therapy in CBS/PSP</th>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Midbrain (rostral)</td>
<td>Vertical gaze control</td>
</tr>
<tr>
<td class="label">Superior colliculus</td>
<td>Saccade generation</td>
</tr>
<tr>
<td class="label">Rostral interstitial MLF</td>
<td>Vertical saccade control</td>
</tr>
<tr>
<td class="label">Pontine omnipause neurons</td>
<td>Saccade gating</td>
</tr>
<tr>
<td class="label">Frontal eye fields</td>
<td>Voluntary saccade control</td>
</tr>
<tr>
<td class="label">Basal ganglia</td>
<td>Saccade suppression</td>
</tr>
<tr>
<td class="label">Medication</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">3,4-Diaminopyridine</td>
<td>Potassium channel blocker</td>
</tr>
<tr>
<td class="label">Zolpidem</td>
<td>GABA-A modulator</td>
</tr>
<tr>
<td class="label">Botulinum toxin</td>
<td>Neuromuscular blocking</td>
</tr>
<tr>
<td class="label">Exercise</td>
<td>Duration</td>
</tr>
<tr>
<td class="label">Horizontal target pursuit</td>
<td>5 min</td>
</tr>
<tr>
<td class="label">Vertical target pursuit</td>
<td>5 min</td>
</tr>
<tr>
<td class="label">Memory-guided saccades</td>
<td>5 min</td>
</tr>
<tr>

Section 251: Advanced Vision and Eye Movement Therapy in CBS/PSP

Overview

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Section 251: Advanced Vision and Eye Movement Therapy in CBS/PSP</th>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Midbrain (rostral)</td>
<td>Vertical gaze control</td>
</tr>
<tr>
<td class="label">Superior colliculus</td>
<td>Saccade generation</td>
</tr>
<tr>
<td class="label">Rostral interstitial MLF</td>
<td>Vertical saccade control</td>
</tr>
<tr>
<td class="label">Pontine omnipause neurons</td>
<td>Saccade gating</td>
</tr>
<tr>
<td class="label">Frontal eye fields</td>
<td>Voluntary saccade control</td>
</tr>
<tr>
<td class="label">Basal ganglia</td>
<td>Saccade suppression</td>
</tr>
<tr>
<td class="label">Medication</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">3,4-Diaminopyridine</td>
<td>Potassium channel blocker</td>
</tr>
<tr>
<td class="label">Zolpidem</td>
<td>GABA-A modulator</td>
</tr>
<tr>
<td class="label">Botulinum toxin</td>
<td>Neuromuscular blocking</td>
</tr>
<tr>
<td class="label">Exercise</td>
<td>Duration</td>
</tr>
<tr>
<td class="label">Horizontal target pursuit</td>
<td>5 min</td>
</tr>
<tr>
<td class="label">Vertical target pursuit</td>
<td>5 min</td>
</tr>
<tr>
<td class="label">Memory-guided saccades</td>
<td>5 min</td>
</tr>
<tr>
<td class="label">Anti-saccade training</td>
<td>5 min</td>
</tr>
<tr>
<td class="label">Prism Type</td>
<td>Indication</td>
</tr>
<tr>
<td class="label">Base-down prisms</td>
<td>Downward gaze palsy</td>
</tr>
<tr>
<td class="label">Base-up prisms</td>
<td>Upward gaze palsy</td>
</tr>
<tr>
<td class="label">Yoked prisms</td>
<td>Generalized gaze limitation</td>
</tr>
<tr>
<td class="label">Fresnel prisms</td>
<td>Temporary/trial correction</td>
</tr>
<tr>
<td class="label">Exercise</td>
<td>Duration</td>
</tr>
<tr>
<td class="label">Horizontal sweep</td>
<td>2 min</td>
</tr>
<tr>
<td class="label">Vertical sweep</td>
<td>2 min</td>
</tr>
<tr>
<td class="label">Circular pursuit</td>
<td>3 min</td>
</tr>
<tr>
<td class="label">Figure-eight</td>
<td>3 min</td>
</tr>
<tr>
<td class="label">Professional</td>
<td>Role</td>
</tr>
<tr>
<td class="label">Neuro-ophthalmologist</td>
<td>Medical management, differential diagnosis</td>
</tr>
<tr>
<td class="label">Optometrist</td>
<td>Prism fitting, optical aids</td>
</tr>
<tr>
<td class="label">Occupational therapist</td>
<td>Daily living adaptations, home assessment</td>
</tr>
<tr>
<td class="label">Speech-language pathologist</td>
<td>AAC selection, communication training</td>
</tr>
<tr>
<td class="label">Physical therapist</td>
<td>Balance and mobility with visual compensation</td>
</tr>
<tr>
<td class="label">Orthoptist</td>
<td>Eye movement assessment and training</td>
</tr>
<tr>
<td class="label">Intervention</td>
<td>Evidence Level</td>
</tr>
<tr>
<td class="label">Prismatic lenses</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Saccade training</td>
<td>Low-Moderate</td>
</tr>
<tr>
<td class="label">Eye-gaze AAC</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Vision rehabilitation</td>
<td>Moderate</td>
</tr>
</table>

This section provides comprehensive coverage of vision and eye movement therapy interventions for corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). These disorders cause profound oculomotor dysfunction, with vertical supranuclear gaze palsy being a hallmark feature of PSP and horizontal saccadic deficits common in CBS. This section addresses therapeutic approaches including vertical gaze palsy management, eye tracking exercises, prismatic lens therapy, vision rehabilitation protocols, saccadic training, pursuit therapy, and adaptive technologies.

Oculomotor dysfunction in CBS and PSP results from degeneration of brainstem nuclei and cortical pathways controlling eye movements. Vertical supranuclear gaze palsy, characterized by impaired downward and upward saccades, is present in over 70% of PSP patients and represents one of the most disabling features, profoundly affecting reading, navigation, face-to-face communication, and activities of daily living[@chen2020]. While these neuro degenerative changes are progressive, targeted rehabilitation approaches can improve functional visual abilities, compensate for deficits, and enhance quality of life.

Building upon the diagnostic eye tracking content in [Eye Tracking and Saccade Testing in PSP](/diagnostics/eye-tracking-saccade-psp), this section focuses on therapeutic interventions. Related sections include [Section 250: Advanced Vestibular and Balance Therapy](/therapeutics/section-250-advanced-vestibular-balance-therapy-cbs-psp), which addresses postural stability aspects of oculomotor dysfunction, and [Section 249: Advanced LSVT Voice and Speech Therapy](/therapeutics/section-249-advanced-lsvt-voice-speech-therapy-cbs-psp), which covers communication strategies that complement visual rehabilitation.

1. Pathophysiology of Oculomotor Dysfunction in CBS/PSP

1.1 Neuroanatomical Basis

The oculomotor abnormalities in CBS and PSP arise from selective degeneration of specific neuronal populations controlling eye movements:

1.2 Characteristic Oculomotor Patterns

PSP-Specific Patterns:

• Vertical supranuclear gaze palsy (initially downward > upward)
• Reduced vertical saccade velocity (< 50% of normal)
• Square wave jerks (involuntary horizontal oscillations)
• Eyelid opening apraxia
• Blepharospasm
• Impaired convergence

• Horizontal saccadic slowing
• Impaired anti-saccade tasks
• Increased saccadic latency
• Saccadic hypometria
• Oculomotor apraxia (difficulty initiating voluntary saccades)

2. Vertical Gaze Palsy Management

2.1 Assessment and Baseline Documentation

Effective management begins with comprehensive oculomotor assessment to establish baseline function and track progression:

Standardized Assessments:

Assessment Protocol:

• Document primary gaze (primary position)
• Measure horizontal and vertical saccade range
• Assess smooth pursuit gain
• Test optokinetic nystagmus
• Evaluate convergence and accommodation

2.2 Compensatory Strategies

While the underlying neuro degeneration cannot be reversed, patients can learn compensatory strategies:

Head Maneuvers:

• Chin-tilt technique: Tilting head upward to bring objects into horizontal gaze plane
• Turn-and-look strategy: Using head turning to compensate for limited vertical movement
• Prone position: Lying prone allows downward gaze through head movement

• Position computer monitors at eye level
• Use document holders at comfortable viewing angles
• Arrange home environment to minimize need for vertical gaze
• Install task lighting to reduce need for vertical eye movements

2.3 Pharmacological Considerations

Limited pharmacological options exist for oculomotor dysfunction:

3. Eye Tracking Exercises

3.1 Rationale and Evidence

Eye tracking exercises aim to improve oculomotor function through targeted practice. While neuro degeneration limits reversal of pathology, training can enhance remaining function and improve compensatory strategies[@goldberg2012].

Theoretical Basis:

• Neuroplasticity in remaining oculomotor neurons
• Improved motor learning for saccadic control
• Enhanced visual attention and target selection
• Practice-dependent improvement in smooth pursuit

3.2 Saccadic Training Protocol

Phase 1: Basic Saccade Training (Weeks 1-4)

Exercise Procedure:

Phase 2: Functional Saccade Training (Weeks 5-8)

• Reading saccade exercises (line-by-line)
• Face-tracking exercises (social interaction simulation)
• Navigation saccade training (simulated environment traversal)

• Daily 10-minute maintenance sessions
• Weekly progress assessments
• Monthly VOG follow-up

3.3 Smooth Pursuit Therapy

Pursuit Eye Movement Exercises:

Parameters:

• Target speed: Start at 10°/s, progress to 30°/s
• Target size: 2-5 degrees visual angle
• Background: High contrast, low distraction
• Session length: 5-10 minutes

4. Prismatic Lens Therapy

4.1 Principles of Prismatic Adaptation

Prismatic lenses shift the visual field to compensate for gaze limitations. Base-down prisms shift images upward, allowing patients with limited downward gaze to see without tilting the head downward[@antoniades2017].

Types of Prismatic Corrections:

4.2 Fitting Protocol

Assessment:

Fitting Procedure:

4.3 Clinical Outcomes

Prismatic adaptation has shown efficacy in PSP:

• Improved reading ability in 60-70% of patients
• Reduced head tilt during visual tasks
• Enhanced quality of life scores
• Benefits maintained over 6-12 month follow-up[@uc2019]

5. Vision Rehabilitation

5.1 Low Vision Assessment

Comprehensive low vision evaluation is essential for CBS/PSP patients:

Assessment Components:

• Distance and near visual acuity
• Contrast sensitivity
• Visual field testing
• Reading speed and accuracy
• glare sensitivity

5.2 Optical Aids

Magnification Devices:

• Handheld magnifiers (2x-10x)
• Stand magnifiers
• Video magnifiers (CCTV)
• Spectacle-mounted telescopes
• Clip-on telescopic lenses

• High-contrast labels
• Large-print materials
• Task lamps with adjustable intensity
• Anti-glare filters
• Contrast-enhancing filters (yellow, amber)

5.3 Eccentric Viewing Training

For patients with central vision involvement or gaze limitations:

Techniques:

6. Saccadic Training

6.1 Discrete Saccade Exercises

ProSaccade Training:

• Random target appearance at various positions
• React and move eyes as quickly as possible
• Focus on accuracy and speed
• Progress from large to small target displacements

• Gap paradigm: Fixation point disappears before target appears
• Overlap paradigm: Fixation remains while target appears
• Training improves saccade initiation

6.2 Anti-Saccade Training

Anti-saccade tasks train voluntary saccade control:

• Fixate on central target
• When peripheral target appears, look in OPPOSITE direction
• Inhibit reflexive glance toward stimulus
• Critical for social situations and reading

6.3 Memory-Guided Saccades

• Fixate on target location
• Target disappears
• After delay, execute saccade to remembered location
• Trains working memory and voluntary control

6.4 Technology-Assisted Training

Commercial Systems:

• [EyeTrack](https://www.eyetracking.com/) — Research-grade tracking with training modules
• [Tobii Dynavox](https://www.tobii.com/) — Communication and eye control devices
• [CureMD](https://www.curemd.com/) — Oculomotor rehabilitation software

• Simple dot-following games on tablet
• Web-based saccade training (e.g., King-Devick apps)
• Paper-based exercises with therapist guidance

7. Pursuit Therapy

7.1 Smooth Pursuit Enhancement

Training Principles:

7.2 Predictable Pursuit Exercises

7.3 Unpredictable Pursuit

• Random direction changes
• Variable speeds
• Multiple targets
• Background distractors

8. Adaptive Technologies

8.1 Eye-Gaze Communication Systems

For patients with severe oculomotor impairment, eye-gaze AAC (Augmentative and Alternative Communication) systems enable communication[@romberg2021]:

Hardware Options:

• Eye-tracking camera mounted on tablet
• Dedicated AAC device with eye-gaze control
• Computer-based eye-gaze interface

• [Tobii Dynavox Compass](https://www.tobii.com/) — Communication software
• [Grid 3](https://www.grid3.com/) — Symbol-based communication
• [Gaze Point](https://www.gazepoint.com/) — Research and communication

• Head position tolerance
• Lighting requirements
• Calibration precision
• Fatigue considerations

8.2 Environmental Control Units

Eye-gaze controlled home automation:

• Lighting control
• Television/sound system
• Thermostat
• Door controls
• Emergency call systems

8.3 Reading and Computer Access

Technology Solutions:

• [OpenBook](https://www.opentext.com/) — OCR and reading software
• [DAISY readers](https://www.daisy.org/) — Accessible book format
• Voice control software (Dragon NaturallySpeaking)
• Screen readers (JAWS, NVDA)

• Eye-gaze mouse control
• Head tracking mice
• Switch scanning for limited mobility

8.4 Smartphone and Tablet Adaptations

• Large text and icon settings
• VoiceOver/TalkBack screen readers
• Eye-control apps (SeeColors, Glance)
• Simplified launcher interfaces

9. Integrated Treatment Protocols

9.1 Comprehensive Vision Therapy Program

Week 1-2: Assessment Phase

• Baseline VOG testing
• Functional vision assessment
• Goal setting with patient/caregiver
• Equipment selection

• Daily eye tracking exercises (30 min)
• Prismatic lens fitting and adjustment
• Technology orientation
• Weekly therapy sessions

• Continued daily exercises (15-20 min)
• Monthly progress assessment
• Equipment refinement
• Caregiver training

9.2 Home Exercise Program

Daily Routine (30 minutes):

9.3 Interdisciplinary Care

Effective vision therapy requires coordination:

10. Clinical Outcomes and Evidence

10.1 Evidence Summary

10.2 Prognostic Factors

Favorable Prognostic Factors:

• Earlier intervention (before severe gaze palsy)
• Preserved cognitive function
• Active participation in therapy
• Strong caregiver support
• Adequate lighting and environmental control

• Advanced vertical gaze palsy at presentation
• Significant cognitive impairment
• Severe blepharospasm
• Rapid disease progression

11. Caregiver Education and Support

11.1 Practical Strategies for Caregivers

Communication:

• Position yourself at eye level when speaking
• Use hand gestures to direct attention
• Announce your presence before approaching
• Allow extra time for visual processing

• Ensure adequate lighting (avoid glare)
• Minimize background clutter
• Use high-contrast items
• Label important locations clearly

• Warn patient before moving around them
• Guide hand to objects when needed
• Prevent accidents during head turns
• Monitor for aspiration during meals (gaze affects swallowing)

11.2 Resources

Organizations:

• [PSP Association (UK)](https://www.pspassociation.org.uk/)
• [CurePSP](https://www.curepsp.org/)
• [Foundation for PSP | CBD | Related Brain Diseases](https://www.psp.org/)
• [American Academy of Ophthalmology](https://www.aao.org/)

• Low vision rehabilitation services
• Orientation and mobility training
• Support groups for atypical parkinsonism
• Respite care for caregivers

12. Future Directions

12.1 Emerging Therapies

• Non-invasive brain stimulation: TMS/tDCS for oculomotor control
• Virtual reality training: Immersive eye exercise environments
• Wearable biofeedback: Real-time saccade monitoring
• Gene therapy: Targeting tau pathology affecting oculomotor nuclei

12.2 Research Priorities

Summary

Vision and eye movement therapy in CBS/PSP addresses one of the most disabling aspects of these disorders. While the underlying neurodegeneration cannot be reversed, comprehensive rehabilitation can significantly improve functional vision, communication, and quality of life. Key interventions include:

• Vertical gaze palsy management: Compensatory strategies and environmental modifications
• Eye tracking exercises: Saccadic and pursuit training to maintain function
• Prismatic lens therapy: Optical compensation for gaze limitations
• Vision rehabilitation: Low vision services and adaptive aids
• Adaptive technologies: Eye-gaze communication and environmental control

References